These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 11101192)

  • 1. T-type calcium channel blockade in the management of chronic ischemic heart disease.
    Marsh JD; Antman EM
    Cardiovasc Drugs Ther; 2000 Oct; 14(5):459-61. PubMed ID: 11101192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of mibefradil on ischemic episodes with and without increase in heart rate.
    Tzivoni D; Gilula Z; Klutstein MW; Reisin L; Botvin S; Kobrin I
    Cardiovasc Drugs Ther; 2000 Oct; 14(5):503-9. PubMed ID: 11101198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized comparison of T-type versus L-type calcium-channel blockade on exercise duration in stable angina: results of the Posicor Reduction of Ischemia During Exercise (PRIDE) trial.
    Lee DS; Goodman S; Dean DM; Lenis J; Ma P; Gervais PB; Langer A;
    Am Heart J; 2002 Jul; 144(1):60-7. PubMed ID: 12094189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective L-type, T-type, and nonspecific calcium-channel blockers for stable angina pectoris.
    Thadani U
    Am Heart J; 2002 Jul; 144(1):8-10. PubMed ID: 12094182
    [No Abstract]   [Full Text] [Related]  

  • 5. Mechanism of the antiischemic effect of mibefradil, a selective T calcium channel blocker in dogs: comparison with amlodipine.
    Roux S; Bühler M; Clozel JP
    J Cardiovasc Pharmacol; 1996 Jan; 27(1):132-9. PubMed ID: 8656647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of calcium channel blockers and beta blockers for patients with exercise-induced angina pectoris: a double-blind parallel-group comparison of different classes of calcium channel blockers. The Netherlands Working Group on Cardiovascular Research (WCN).
    van der Vring JA; Daniëls MC; Holwerda NJ; Withagen PJ; Schelling A; Cleophas TJ; Hendriks MG
    Angiology; 1999 Jun; 50(6):447-54. PubMed ID: 10378820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative pharmacological properties among calcium channel blockers: T-channel versus L-channel blockade.
    Noll G; Lüscher TF
    Cardiology; 1998; 89 Suppl 1():10-5. PubMed ID: 9570424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a new calcium antagonist, mibefradil (Ro 40-5967), on silent ischemia in patients with stable chronic angina pectoris: a multicenter placebo-controlled study. The Mibefradil International Study Group.
    Braun S; van der Wall EE; Emanuelsson H; Kobrin I
    J Am Coll Cardiol; 1996 Feb; 27(2):317-22. PubMed ID: 8557900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrasting effects of selective T- and L-type calcium channel blockade on glomerular damage in DOCA hypertensive rats.
    Karam H; Clozel JP; Bruneval P; Gonzalez MF; Ménard J
    Hypertension; 1999 Oct; 34(4 Pt 1):673-8. PubMed ID: 10523345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-anginal and anti-ischemic effects of mibefradil, a new T-type calcium channel antagonist.
    Kobrin I; Bieska G; Charlon V; Lindberg E; Pordy R
    Cardiology; 1998; 89 Suppl 1():23-32. PubMed ID: 9570426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mibefradil, a T-type and L-type calcium channel blocker, limits infarct size through a glibenclamide-sensitive mechanism.
    Mocanu MM; Gadgil S; Yellon DM; Baxter GF
    Cardiovasc Drugs Ther; 1999 Apr; 13(2):115-22. PubMed ID: 10372226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antianginal and anti-ischemic effects of mibefradil in the treatment of patients with chronic stable angina pectoris.
    Alpert JS; Bakx AL; Braun S; Frishman WH; Schneeweiss A; Tzivoni D; Kobrin I
    Am J Cardiol; 1997 Aug; 80(4B):20C-26C. PubMed ID: 9286850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mibefradil, a T-type calcium channel blocker, and abnormal rhythm in subacute myocardial infarction.
    Boutjdir M
    J Cardiovasc Electrophysiol; 1999 Sep; 10(9):1236-9. PubMed ID: 10517657
    [No Abstract]   [Full Text] [Related]  

  • 14. Combination of calcium channel blockers and beta-blockers for patients with exercise-induced angina pectoris: beneficial effect of calcium channel blockers largely determined by their effect on heart rate.
    Cleophas TJ; van der Sluijs J; van der Vring JA; Daniëls MC; Holwerda KJ; Withagen AJ; Schelling A; Hendriks MG; Zwinderman AH
    J Clin Pharmacol; 1999 Jul; 39(7):738-46. PubMed ID: 10392329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of mibefradil, a novel calcium channel blocking agent with T-type activity, in acute experimental myocardial ischemia: maintenance of ventricular fibrillation threshold without inotropic compromise.
    Muller CA; Opie LH; McCarthy J; Hofmann D; Pineda CA; Peisach M
    J Am Coll Cardiol; 1998 Jul; 32(1):268-74. PubMed ID: 9669280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential cardioprotective effect of mibefradil in the long-term treatment of hypertension.
    Waeber B
    Cardiology; 1998; 89 Suppl 1():16-22. PubMed ID: 9570425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mibefradil--a T-type calcium channel blocker].
    Roguin A; Edoute Y
    Harefuah; 1999 Jan; 136(2):167-9. PubMed ID: 10914190
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of mibefradil, a T-type calcium channel blocker, on morbidity and mortality in moderate to severe congestive heart failure: the MACH-1 study. Mortality Assessment in Congestive Heart Failure Trial.
    Levine TB; Bernink PJ; Caspi A; Elkayam U; Geltman EM; Greenberg B; McKenna WJ; Ghali JK; Giles TD; Marmor A; Reisin LH; Ammon S; Lindberg E
    Circulation; 2000 Feb; 101(7):758-64. PubMed ID: 10683349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the calcium channel antagonist mibefradil on haemodynamic parameters and myocardial Ca(2+)-handling in infarct-induced heart failure in rats.
    Sandmann S; Min JY; Meissner A; Unger T
    Cardiovasc Res; 1999 Oct; 44(1):67-80. PubMed ID: 10615391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Voltage-gated T-type Ca2+ channels and heart failure.
    Clozel JP; Ertel EA; Ertel SI
    Proc Assoc Am Physicians; 1999; 111(5):429-37. PubMed ID: 10519164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.